Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Micardis

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Micardis was produced by Boehringer Ingelheim and Astellas.

Boehringer Ingelheim returns to growth after US turnaround

Boehringer Ingelheim returns to growth after US turnaround

Boehringer's heart drug Micardis (telmisartan) continued to suffer the effects of generic competition, with sales down 12.1% to 956m, but 2015 also saw the company's diabetes portfolio making

Humira remains top pharma product, but Sovaldi closes in

Humira remains top pharma product, but Sovaldi closes in Boehringer has seen a similar situation with its heart drug Micardis(telmisartan) that has been losing patent protection for over a year.

Heart drug sales continue downward spiral

Heart drug sales continue downward spiral Finally Boehringer, which saw the largest drop in the top ten table due predominately to the patent loss of Micardis (telmisartan).

Boehringer's sales drop after 'intense and challenging' year

Boehringer's sales drop after 'intense and challenging' year During the year all four of Boehringer's top products saw their global sales decline, most noticeably cardiovascular drug Micardis (telmisartan) and COPD treatment Combivent (ipratropium and albuterol), both of which

Micardis

Micardis campaign. Created by Seven Stones for Boehringer Ingelheim. Therapy area: Cardiovascular

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics